# $goss

Anticipation is high for $GOSS's upcoming Phase [--] readout, with analysts setting aggressive price targets, though options markets are pricing in a significant risk of failure.

### About $goss
$GOSS refers to a decentralized digital currency and its associated blockchain technology.  

### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$goss/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$goss/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [-----]  
[--] Week: [---] +46,100%  
[--] Month: [-------] -48%  
[--] Months: [---------] +128%  
[--] Year: [---------] +197%  
1-Year High: [-------] on 2025-12-24  
1-Year Low: [--] on 2025-05-10  

Engagements by network (24h):
Reddit: [--]
X: [------]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$goss/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$goss/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [-----] on 2025-07-10  
1-Year Low: [--] on 2025-04-27  

Mentions by network (24h):
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$goss/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$goss/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $goss in the last [--] hours which is down 15% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-27  

The most influential creators that mention $goss in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [------]      |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [-----]       |
| [@avidresearch](/creator/twitter/avidresearch)       | [--]    | [------]    | [--]     | [-----]       |
| [@Buffalo51766917](/creator/twitter/Buffalo51766917) | [--]    | [---]       | [--]     | [---]         |
| [@DanVibes10](/creator/twitter/DanVibes10)           | [--]    | [-----]     | [--]     | [---]         |
| [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) | [--]    | [-----]     | [--]     | [---]         |
| [@TeresaTrades](/creator/twitter/TeresaTrades)       | [--]    | [------]    | [--]     | [---]         |
| [@trentkelp](/creator/twitter/trentkelp)             | [--]    | [-----]     | [--]     | [---]         |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | [--]    | [--]        | [--]     | [--]          |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]   | [-----]     | [--]     | [--]          |

[View More](/list/creators/$goss/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$goss/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$goss/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 85%  
[--] Month: 95% +38%  
[--] Months: 95% -5%  
[--] Year: 95% +20%  
1-Year High: 100% on 2025-02-18  
1-Year Low: 14% on 2025-11-11  

Most Supportive Themes:
- Positive Phase [--] Readout Anticipation: (40%) Multiple posts express optimism about an upcoming Phase [--] readout for $GOSS, with analysts from Barclays, HC Wainwright, and Piper Sandler providing supportive price targets.
- Potential for Disease Modification and Market Share: (30%) Discussions highlight $GOSS's potential as a second disease-modifying drug, with analysis on how it could capture market share by catering to specific patient groups or offering convenience.
- Biotech Catalyst Watchlist Inclusion: (20%) $GOSS is listed among key biotech stocks with upcoming Phase [--] and Phase [--] readouts in Q1 2026, indicating significant industry attention.
  
Most Critical Themes:
- Options Market Pricing in Failure Risk: (10%) Options data suggests a 70% probability of failure for the Phase [--] readout, with concerns about patient enrollment and statistical significance in previous phases.
  

### Top $goss Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$GOSS Cantor Gossamer is dominating investor conversations right now.reality is investors are split. We hear 60/40 in favor just as often as 40/60 against and the stock is pricing in exactly that. Core Debate biggest overhang remains the mixed Phase [--] data and the OLE - specifically the delayed catch-up in the placebo cross-over arm.From W24 to W72 improvement in PVR and 6MWD in the cross-over group was modest compared to what the original seralutinib arm showed from W0 to W24. Theres a thoughtful write-up in Advances in Therapy that walks through this"  
[X Link](https://x.com/semodough/status/2022796619637235980) [@semodough](/creator/x/semodough) 2026-02-14T22:14Z 42.5K followers, [----] engagements


"The ones that make me money lol 😆 Just playing around. I trade optoins mostly so I constantly change what playing. Right now im though holding $GOSS and selling contracts against it. Also buying dips as it seems to tange looking at it. I dont like the crypto etfs as they dont move the same and would rather just have the crypto and not an etf. https://twitter.com/i/web/status/2022724748287807860 https://twitter.com/i/web/status/2022724748287807860"  
[X Link](https://x.com/DanVibes10/status/2022724748287807860) [@DanVibes10](/creator/x/DanVibes10) 2026-02-14T17:28Z [----] followers, [---] engagements


"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"  
[X Link](https://x.com/BiopharmIQ/status/2022703288546922772) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-14T16:03Z 28.9K followers, [----] engagements


"$GOSS Here we go https://discord.gg/MDwcnss7RY https://discord.gg/MDwcnss7RY"  
[X Link](https://x.com/BullForex24/status/2022702783699296696) [@BullForex24](/creator/x/BullForex24) 2026-02-14T16:01Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing